On July 28, the "Inside Listed Companies" series of Alliance Institute's "China Digital Energy Entrepreneurs" program continued with momentum. In the afternoon, the cohort visited Mindray Medical (300760.SZ), known as the "Huawei of the Medical Industry," to explore the core secrets behind this leading domestic medical device company's successful high-quality development.
Upon arriving at Mindray Medical's headquarters, the participants embarked on an in-depth tour. As a global leader in medical devices and solutions, Mindray has adhered to a path of independent research and development since its establishment in 1991. It has gradually grown into an industry giant with products covering three major fields: Life Information & Support, In Vitro Diagnostics (IVD), and Medical Imaging. Its business now extends to more than 190 countries and regions worldwide.
In the corporate exhibition hall, participants learned in detail about Mindray's development history. From initially representing imported equipment to independently developing its first pulse oximeter monitor, and now competing on the same stage as international giants in high-end medical equipment, Mindray's growth trajectory is a vivid microcosm of China's medical device industry transforming from following to keeping pace, and finally to leading the way.
A series of high-end products left a deep impression on the participants. In the Life Information & Support field, Mindray's intelligent monitoring systems, anesthetic machines, and ventilators are widely used in top medical institutions globally. In IVD, its fully automatic chemiluminescence immunoassay systems and blood cell analyzers have reached international advanced levels. In Medical Imaging, Mindray's ultrasound equipment has ranked among the top three globally for consecutive years.
Of particular note was Mindray's breakthrough in high-end ultrasound. Its Resona series, equipped with the independently developed ZST+ Zone Sonography Technology, offers image quality comparable to top international brands, successfully breaking the long-term monopoly of foreign manufacturers in the high-end market. One participant reflected, "In the past, we assumed high-end medical equipment was the domain of imported brands. Today, seeing Mindray, we realize that Chinese manufacturing can also reach world-class standards."
Through in-depth communication with corporate experts, participants learned that Mindray consistently invests about 10% of its annual revenue in R&D, a ratio far higher than the industry average. Currently, Mindray operates ten R&D centers worldwide, employs nearly 4,000 R&D personnel, and has applied for nearly 10,000 patents, over 70% of which are invention patents.
This persistent pursuit of innovation has enabled Mindray to secure a place in the highly competitive global market and continue leading industry development. In 2022, Mindray achieved operating income of 30.37 billion yuan, a year-on-year increase of 20.2%; net profit attributable to owners of the parent company was 9.61 billion yuan, up 21.6%, demonstrating strong momentum in high-quality development.
The visit allowed participants to deeply understand that high-quality development cannot be separated from continuous technological accumulation and innovative breakthroughs. Whether in medical devices or the energy industry, technology is the core competitiveness, and innovation is the most lasting driving force.
Additionally, the integration of healthcare and energy digitalization offered new inspiration for cross-border thinking. From energy management in smart hospitals to reliable power supply guarantees for medical equipment, and the combination of telemedicine with 5G technology, the intersection of energy and healthcare contains huge space for innovation. One participant noted, "Mindray's experience shows that focusing on the main business, continuous investment, and pursuing excellence are the common paths to achieving high-quality development in any industry."
The visit to Mindray not only allowed participants to get up close to a leading domestic medical device company but also deepened everyone's understanding of the essence of high-quality development. It is not a slogan but requires substantial technological accumulation, continuous R&D investment, and an ultimate pursuit of quality.
Technology and innovation are the driving forces for enterprises to maintain vitality. Only through continuous innovation can enterprises achieve long-term stability and sustainable development. The visit to Mindray was not only a learning tour to a benchmark enterprise but also stimulated ideas and enlightened the future, bringing valuable cross-industry inspiration to the energy sector.